Press releases

• 2020-07-06

  NeoDynamics restarts patient recruitment to UK COMPULSE Study to optimize diagnosis of breast cancer

  STOCKHOLM - July 6, 2020. NeoDynamics AB (Spotlight Stock Market: NEOD), announces that the Company restarts patient recruitment to the UK COMPULSE Study following a temporary pause imposed by the COVID-19 pandemic. Read more

• 2020-05-26

  NeoDynamics AB (publ) First Quarter 2020

  Somewhat higher development cost, but mainly in line Read more

• 2020-02-05

  NeoDynamics AB (publ) full-year report 2019

  Summing up a productive 2019 Read more